AT35705B - Process for the production of easily soluble gelatin capsules. - Google Patents
Process for the production of easily soluble gelatin capsules.Info
- Publication number
- AT35705B AT35705B AT35705DA AT35705B AT 35705 B AT35705 B AT 35705B AT 35705D A AT35705D A AT 35705DA AT 35705 B AT35705 B AT 35705B
- Authority
- AT
- Austria
- Prior art keywords
- production
- gelatin capsules
- easily soluble
- soluble gelatin
- capsules
- Prior art date
Links
- 239000007903 gelatin capsule Substances 0.000 title description 3
- 238000004519 manufacturing process Methods 0.000 title description 3
- 238000000034 method Methods 0.000 title description 2
- 239000002775 capsule Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
<Desc/Clms Page number 1>
Verfahren zur Herstellung von leicht löslichen Gelatinekapseln.
Eine gebräuchliche Art und Weise, Medikamente zu verabreichen, die wegen ihres Geschmackes oder aus anderen Gründen nicht direkt eingenommen werden, besteht darin,
EMI1.1
Obgleich diese Arzneiform sehr bequem ist, so ist ihre Anwendung doch nicht unbedenklich, da diese Kapseln bisweilen im Verdauungskanale nicht gelöst werden.
Die vorliegende Erfindung hebt diesen Nachteil der Gelatinekapseln auf, indem bei der Herstellung der Kapseln der Gelatine Enzyme oder Fermente einverleibt werden, die
EMI1.2
Dies ist dadurch möglich, dass man einmal das Trocknen der Kapseln, das bei gewöhnlicher Temperatur erfolgen kann, möglichst beschleunigt und ferner dadurch, dass man die
EMI1.3
tmtfalten. beispiele :
EMI1.4
einer sauer reagierenden Flüssigkeit zusammenkommen, also im Magen.
. Die sauer reagierende Gelatine wird mit 0. 20/0 Pyocyanase versetzt.
3. Die schwach alkalisch reagierende Gelatine wird mit 0. 2% Papirin versetzt.
Natürlich können die Mengen des Enzymezusatzes in diesen Beispielen geändert werden, ebenso rie der Zusatz indifferenter Stoffe, die die Lösungsgeschwindigkeit der
EMI1.5
**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.
<Desc / Clms Page number 1>
Process for the production of easily soluble gelatin capsules.
A common way of administering drugs that are not taken directly because of their taste or other reasons is to
EMI1.1
Although this dosage form is very convenient, its use is not harmless, as these capsules sometimes do not dissolve in the digestive tract.
The present invention overcomes this disadvantage of gelatin capsules by incorporating enzymes or ferments into the gelatin during the production of the capsules
EMI1.2
This is possible by accelerating the drying of the capsules, which can take place at normal temperature, as much as possible, and also by the
EMI1.3
tmtfalten. examples:
EMI1.4
come together in an acidic liquid, i.e. in the stomach.
. The acidic reacting gelatin is mixed with 0. 20/0 pyocyanase.
3. The slightly alkaline reacting gelatine is mixed with 0.2% papirin.
Of course, the amounts of enzymes added can be changed in these examples, as can the addition of inert substances, which will reduce the rate of dissolution of the
EMI1.5
** WARNING ** End of DESC field may overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT35705T | 1907-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT35705B true AT35705B (en) | 1908-12-28 |
Family
ID=3552342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT35705D AT35705B (en) | 1907-03-29 | 1907-03-29 | Process for the production of easily soluble gelatin capsules. |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT35705B (en) |
-
1907
- 1907-03-29 AT AT35705D patent/AT35705B/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2117429C3 (en) | Process for the production of an injection or infusion preparation with a content of an active substance mixture from the leaves of Ginkgo biloba | |
| DE2855825A1 (en) | ANTIDOT AND ITS USE FOR THE TREATMENT OF POISONING | |
| EP0224157B1 (en) | Oral preparations of garlic and process for their production | |
| AT35705B (en) | Process for the production of easily soluble gelatin capsules. | |
| US2333283A (en) | Administration capsule | |
| DE3509741A1 (en) | ORAL DOSAGE FORM OF ETOPOSIDE | |
| US1046056A (en) | Capsule. | |
| AT81069B (en) | Process for the preservation of extracts from drugs Processes for the preservation of extracts from drugs. en. | |
| DE2559384A1 (en) | Caffeine combinations with nicotinamide - for increased solubility and lower toxicity, used in foods, medicaments and cosmetics | |
| AT92888B (en) | Process for the production of a durable polyvalent vitamin malt preparation. | |
| AT69476B (en) | Process for the production of therapeutically valuable bactericidal preparations. | |
| DE191406C (en) | ||
| AT33122B (en) | Process for the production of a chewing preparation. | |
| DE728188C (en) | Process for the preparation of concentrated solutions of diiodotyrosine | |
| DE748004C (en) | Process for the production of a new reaction product from sulphite waste liquor | |
| AT38536B (en) | Process for the preparation of gallocyanine dyes. | |
| DE2131946A1 (en) | Orotic acid salts with amino alcohols - useful as geriatric medicaments | |
| DE407669C (en) | Process for the production of ether derivatives of nuclear mercured aromatic oxycarboxylic acids | |
| AT230366B (en) | Process for the preparation of new 9-aminoalkyl-9,10-dihydro-9,10-ethano- (1 ', 2') -anthracenes and their salts or quaternary ammonium compounds | |
| AT223751B (en) | Process for the preparation of the new 18-O-methylreserp acid methyl ester | |
| AT226217B (en) | Process for the preparation of the new 5-chloro-4-nitro-2-aminophenol | |
| AT123401B (en) | Process for the preparation of 3.3'-dichloro-4.4'-dioxy-5.5'-bisacylaminoarsenobenzenes. | |
| AT222805B (en) | Process for the preparation of a new derivative of the antibiotic kanamycin | |
| AT38550B (en) | Process for the production of a tannin-silver-protein compound which is insoluble in gastric juice and sparingly soluble in intestinal juice. | |
| AT119480B (en) | Process for the preparation of addition compounds of sulfur dioxide with aromatic p-diamines. |